Position in JNJ
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$15,410,899
+$38,312 QoQ
Shares Held
60,680
-3.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
2.72%
of 13F equity value
Holder Rank
#870
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026XML Financial, LLC holds $41,755,485 across 10 Drug Manufacturers - General names. JNJ ranks #1 (36.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
60,680 | $15,410,899 | |
| 2 | MRK |
Merck & Co., Inc.
|
59,108 | $7,595,378 | |
| 3 | AMGN |
Amgen Inc
|
18,659 | $6,756,797 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
46,441 | $2,675,930 | |
| 5 | ABBV |
AbbVie Inc.
|
9,996 | $2,515,393 | |
| 6 | PFE |
Pfizer Inc
|
99,422 | $2,394,081 | |
| 7 | LLY |
ELI LILLY & Co
|
1,921 | $2,304,105 | |
| 8 | NVS |
Novartis AG
|
5,376 | $842,526 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,410,899 | 60,680 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $15,372,587 | 62,889 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $13,118,353 | 63,389 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $12,728,341 | 68,646 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $10,727,938 | 70,232 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $11,691,056 | 70,496 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $10,056,440 | 69,537 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $11,201,101 | 69,117 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $9,955,688 | 68,115 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $10,841,709 | 68,536 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $11,767,568 | 75,077 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $11,188,301 | 71,835 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $11,847,094 | 71,575 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $10,507,760 | 67,792 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,742,746 | 43,831 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $7,030,197 | 43,035 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $2,742,174 | 15,448 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $7,565,771 | 42,689 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $7,291,687 | 42,624 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $6,853,091 | 42,434 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $2,426,455 | 14,729 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,480,205 | 15,091 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,344,017 | 14,894 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $2,110,075 | 14,173 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,877,129 | 13,348 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $1,883,288 | 14,362 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||